NCT01717482View on ClinicalTrials.gov

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 22, 2019

Study Completion Date

May 22, 2019

Conditions

Lung NeoplasmsCarcinoma, Non-Small-Cell Lung

Interventions

DRUG

Metformin

OTHER

Placebo Comparator

Standard of Care Observation

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Alliance for Clinical Trials in Oncology

OTHER

lead

Mayo Clinic

OTHER